WINNIPEG, MANITOBA -- (MARKET WIRE) -- January 08, 2007 -- Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to introduce Ms. Sandra Benson as Manager, Investor Relations. Ms. Benson will continue to enhance the Company’s corporate image and relationship with investors and business partners.
